Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Remnant lipoproteins

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Polygenic risk scores: how much do they add?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Impact of metabolic dysfunction on cognition in humans

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Relation between plasma and brain lipids

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Plasma concentrations of magnesium and risk of dementia: a general population study of 102 648 individuals

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Arterial hypertension and morphologic abnormalities of cardiac chambers: results from the Copenhagen General Population Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The Danish comorbidity in liver transplant recipients study (DACOLT): a non-interventional prospective observational cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

PURPOSE OF REVIEW: To review recent advances in the field of remnant lipoproteins and remnant cholesterol with a focus on cardiovascular disease risk.

RECENT FINDINGS: In line with previous years' research, current observational, genetic, and mechanistic studies find remnant lipoproteins (defined in different ways) to be involved in atherosclerosis development and cardiovascular disease risk. High concentrations of remnant cholesterol could explain some of the residual risk of cardiovascular disease seen after LDL cholesterol lowering. This will be increasingly important as populations worldwide become more obese and more have diabetes, both of which elevate remnant cholesterol concentrations. Many smaller scale studies and post hoc analyses show that remnant cholesterol can be lowered by different types of drugs; however, results from large scale studies with the primary aim of reducing cardiovascular disease risk through lowering of remnant cholesterol in individuals with elevated concentrations are still missing, although some are under way.

SUMMARY: Remnant cholesterol is a risk factor for cardiovascular disease, and can be lowered by different types of drugs; however, large scale studies of cardiovascular disease risk reduction through remnant lipoprotein lowering are under way.

Original languageEnglish
JournalCurrent Opinion in Lipidology
Volume28
Issue number4
Pages (from-to)300-307
Number of pages8
ISSN0957-9672
DOIs
Publication statusPublished - Aug 2017

    Research areas

  • Journal Article

ID: 52336335